Literature DB >> 29966780

Unfavorable Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage WFNS Grade I.

Jendé L Zijlmans1, Bert A Coert1, René van den Berg2, Marieke E S Sprengers2, Charles B L M Majoie2, W Peter Vandertop3, Dagmar Verbaan1.   

Abstract

BACKGROUND: Patients with an aneurysmal subarachnoid hemorrhage (aSAH) and World Federation of Neurosurgical Societies (WFNS) grade I on admission are generally considered to have a good clinical outcome.
OBJECTIVE: The objective of this study was to assess the actual clinical outcome of WFNS grade I aSAH patients, and to determine which factors are associated with unfavourable outcome.
METHODS: For this prospective cohort study, 132 consecutive patients (age 18 years or older) with a WFNS grade I aSAH admitted to our hospital between December 2011 and January 2016 were eligible. Clinical outcome was measured using the modified Rankin Scale (mRS) at 6-month follow-up. Unfavorable outcome was defined as an mRS score of 3-6. Univariable analyses were performed using logistic regression models.
RESULTS: Of 116 patients, only 5 patients (4%) had an mRS score of 0 and most (65%) had an mRS score of 2. Twenty-five patients (22%) had an unfavorable outcome. Nine (8%) patients died, of whom 4 died during admission. Factors associated with unfavorable outcome were age (per increasing decade: odds ratio [OR]. 1.78; 95% confidence interval [CI], 1.16-2.72), delayed cerebral ischemia (OR, 4.32; 95% CI, 1.63-11.44), pneumonia (OR, 10.75; 95% CI, 1.94-59.46) and meningitis (OR, 28.47; 95% CI, 1.42-571.15).
CONCLUSIONS: Despite their neurologically optimal clinical condition on admission, 1 in 5 patients with WFNS grade I aSAH has an unfavorable clinical outcome or is dead at 6-month follow-up. Additional multivariable analysis in larger patient cohorts is necessary to identify the extent to which preventable complications contribute to unfavorable outcomes in these patients.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aneurysm; Intracranial aneurysm; Neurosurgery; Patient outcome assessment; Ruptured; Stroke; Subarachnoid hemorrhage

Mesh:

Year:  2018        PMID: 29966780     DOI: 10.1016/j.wneu.2018.06.157

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  3 in total

1.  Role of endothelial nitric oxide synthase for early brain injury after subarachnoid hemorrhage in mice.

Authors:  Irina J Lenz; Nikolaus Plesnila; Nicole A Terpolilli
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-30       Impact factor: 6.200

2.  An accurate prognostic prediction for aneurysmal subarachnoid hemorrhage dedicated to patients after endovascular treatment.

Authors:  Han Lu; Gaici Xue; Sisi Li; Yangjiayi Mu; Yi Xu; Bo Hong; Qinghai Huang; Qiang Li; Pengfei Yang; Rui Zhao; Yibin Fang; Qiang Luo; Yu Zhou; Jianmin Liu
Journal:  Ther Adv Neurol Disord       Date:  2022-06-01       Impact factor: 6.430

3.  Early stage neuroglobin level as a predictor of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Chenyu Ding; Dezhi Kang; Pengqiang Chen; Ziliang Wang; Yuanxiang Lin; Dengliang Wang; Zhangya Lin; Jianjun Gu
Journal:  Brain Behav       Date:  2020-02-05       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.